Novartis AG (NVS)
NYSE: NVS · Real-Time Price · USD
132.16
-0.27 (-0.20%)
At close: Dec 5, 2025, 4:00 PM EST
132.22
+0.06 (0.05%)
After-hours: Dec 5, 2025, 7:08 PM EST
Novartis AG Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Novartis AG stock has a target of 118, which predicts a decrease of -10.71% from the current stock price of 132.16.
Analyst Consensus: Sell
* Price targets were last updated on Sep 12, 2025.
Analyst Ratings
The average analyst rating for Novartis AG stock from 3 stock analysts is "Sell". This means that analysts believe this stock is likely to lead to lower returns than market as a whole.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 6 | 6 | 6 | 3 | 4 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 1 | 1 | 1 |
| Total | 6 | 6 | 6 | 4 | 5 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Oct 27, 2025 |
| Goldman Sachs | Goldman Sachs | Hold → Strong Sell Downgrades $119 → $118 | Hold → Strong Sell | Downgrades | $119 → $118 | -10.71% | Sep 12, 2025 |
| UBS | UBS | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Feb 13, 2025 |
| Erste Group | Erste Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 19, 2024 |
| BMO Capital | BMO Capital | Hold Maintains $118 → $120 | Hold | Maintains | $118 → $120 | -9.20% | Oct 30, 2024 |
Financial Forecast
Revenue This Year
56.55B
from 51.72B
Increased by 9.33%
Revenue Next Year
58.10B
from 56.55B
Increased by 2.75%
EPS This Year
9.11
from 5.87
Increased by 55.25%
EPS Next Year
9.37
from 9.11
Increased by 2.78%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 60.1B | 61.7B | ||||
| Avg | 56.5B | 58.1B | ||||
| Low | 53.6B | 53.1B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 16.3% | 9.1% | ||||
| Avg | 9.3% | 2.7% | ||||
| Low | 3.7% | -6.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 9.77 | 10.25 | ||||
| Avg | 9.11 | 9.37 | ||||
| Low | 8.50 | 8.09 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 66.4% | 12.5% | ||||
| Avg | 55.3% | 2.8% | ||||
| Low | 44.7% | -11.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.